Baker Brothers Life Sciences LP, Director, 10% Owner at GENOMIC HEALTH INC (GHDX), sold 90,650 shares at $70.55 ($6.4M) on 2019-01-28, disclosed to the SEC on 2019-01-30.
Open-market sale of $6.4M GHDX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.55 | 16 | $1K | 0.0% |
| 2 | $70.55 | 210 | $15K | 0.2% |
| 3 | $70.55 | 234 | $17K | 0.3% |
| 4 | $70.55 | 361 | $25K | 0.4% |
| 5 | $70.55 | 2,093 | $148K | 2.3% |
| 6 | $70.55 | 2,093 |
| $148K |
| 2.3% |
| 7 | $70.55 | 13,634 | $962K | 14.9% |
| 8 | $70.55 | 13,634 | $962K | 14.9% |
| 9 | $71.35 | 24,660 | $1.8M | 27.3% |
| 10 | $71.35 | 29 | $2K | 0.0% |
| 11 | $71.35 | 24,660 | $1.8M | 27.3% |
| 12 | $71.35 | 3,786 | $270K | 4.2% |
| 13 | $71.35 | 3,786 | $270K | 4.2% |
| 14 | $71.35 | 378 | $27K | 0.4% |
| 15 | $71.35 | 423 | $30K | 0.5% |
| 16 | $71.35 | 653 | $47K | 0.7% |
| Total | $71.07 avg | 90,650 | $6.4M | 100% |
| Filing → |
| IGMS | BUY | 2023-12-15 | $5.4M | — | Filing → |
| MDGL | BUY | 2023-11-21 | $22.1M | — | Filing → |
| BGNE | SELL | 2023-11-14 | $198.6M | — | Filing → |